Table 6.
ALD-related PPPM healthcare costs among Medicaid beneficiaries with HCV and ALD (cases), by ALD type at index ALD diagnosis
| |
Index diagnosis |
|||
|---|---|---|---|---|
| Variables | All ALD-related costs1 | Decompensated cirrhosis | Hepatocellular carcinoma | P-value2 |
| N |
1193 |
1098 |
73 |
|
| Inpatient |
|
|
|
|
| Mean (SD) |
$1,272 ($2,926) |
$1,242 ($2,806) |
$2,093 ($4,539) |
0.624 |
| Median |
$0 |
$0 |
$0 |
|
| IQR |
$0-$1,006 |
$0-$1,056 |
$0-$1,155 |
|
| Outpatient |
|
|
|
|
| Mean (SD) |
$83 ($184) |
$76 ($168) |
$202 ($341) |
0.051 |
| Median |
$23 |
$23 |
$37 |
|
| IQR |
$6-$79 |
$7-$78 |
$8-$157 |
|
| Other costs3 |
|
|
|
|
| Mean (SD) |
$1 ($11) |
$1 ($11) |
$2 ($10) |
<.001 |
| Median |
$0 |
$0 |
$0 |
|
| IQR |
$0-$0 |
$0-$0 |
$0-$0 |
|
| Total costs4 |
|
|
|
|
| Mean (SD) |
$1,356 ($2,981) |
$1,319 ($2,848) |
$2,297 ($4,700) |
0.807 |
| Median | $88 | $96 | $67 | |
Source: Florida Medicaid database: claims with dates of service between July 1, 1998 and June 30, 2008.
Notes: All costs are inflated to 2009 USD using the Medical Care component of the CPI. Costs over the entire follow-up period were divided by the number of eligible patient months to create the PPPM cost estimates.
1 “ALD-Related Costs” includes all patients with HCV and ALD, including 22 patients whose index ALD diagnosis was a transplant procedure or history of transplant.
2 Calculated with the Wilcoxon test for comparison of means.
3 "Other" costs include nursing home, home health, hospice, and other services.
4 "Total costs" include inpatient, outpatient, pharmacy, and other (nursing home, home health, hospice, and other services) costs. Pharmacy and other costs comprised < $5 of mean total ALD-related costs in each cohort.
ALD advanced liver disease, HCV hepatitis C virus, PPPM per-patient-per-month.